All AbMole products are for research use only, cannot be used for human consumption.
Cyclophosphamide inhibits the AChE reversibly with an IC50 of 511 microM. The Michaelis-Menten constant (Km) was 132 microM for AChE in the control system; a value increased by 78% in the CP treated system. The Vmax was 73.8 mumol/h/mg protein for the control system. Cyclophosphamide is used to treat cancers and autoimmune disorders. Cyclophosphamide belongs to a group of drugs called alkylating agents. It works by sticking to one of the cancer cell's DNA strands. DNA is the genetic code that is in the heart of all animal and plant cells. It controls everything the cell does.The cell cannot then divide into 2 new cells.
*The compound is unstable in solutions, freshly prepared is recommended
 |
Source | Mol Cancer Ther (2015). Figure 5.Cyclophosphamide |
| Method | i.p. | |
| Cell Lines | NCR/nu and nu/nu nude mice | |
| Concentrations | 170 mg/kg | |
| Incubation Time | 24 h | |
| Results | Cyclophosphamide induced a significant increase of DiI5-liposome MFI at each of the distances from blood vessels analyzed. |
 |
Source | Mol Cancer Ther (2015). Figure 1.Cyclophosphamide |
| Method | i.p. | |
| Cell Lines | NCR/nu and nu/nu nude mice | |
| Concentrations | 170 mg/kg | |
| Incubation Time | 24 h | |
| Results | BT474-M3 tumor–bearing mice were predosed with cyclophosphamide (170 mg/kg) 2 to 5 days before injection of HER2-tPLD or free doxorubicin (both at 3 mg/kg). |
| Cell Experiment | |
|---|---|
| Cell lines | CD4+ T-cell |
| Preparation method | Total CD4+ T cells, labeled with αCD25 BV605, were cultured for 3 days in RPMI/10% AB containing 0 or 50 IU/mL IL-2 as indicated, in presence of CPA (0 μM-1000 μM), mafosfamide (MAF; stabilized active derivative of CPA) (0 μM, 1.2 μM, 12 μM), and/or verapamil (10 μM). Doses of CPA and MAF were titrated to identify doses discriminating sensitivity of Treg and non-Treg cell subsets. |
| Concentrations | 0 μM, 1.2 μM, 12 μM |
| Incubation time | 3 d |
| Animal Experiment | |
|---|---|
| Animal models | Sprague–Dawley rats |
| Formulation | |
| Dosages | 25mg/kg |
| Administration | i.v. |
| Molecular Weight | 261.09 |
| Formula | C7H15Cl2N2O2P |
| CAS Number | 50-18-0 |
| Solubility (25°C) | DMSO 35 mg/mL Water 30 mg/mL |
| Storage | 2-8°C |
[2] al-Jafari AA, et al. Toxicology. Inhibition of human acetylcholinesterase by cyclophosphamide.
| Related DNA/RNA Synthesis Products |
|---|
| Dencatistat
Dencatistat (P115) is an inhibitor of Cytidine Triphosphate Synthase 1 (CTPS1) with an IC50 value of ≤ 0.1 μM. |
| Antipain dihydrochloride
Antipain dihydrochloride is a protease inhibitor. Antipain dihydrochloride inhibits N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced transformation and increases chromosomal aberrations. Antipain dihydrochloride also restricts uterine DNA synthesis and function in mice. |
| Tetrahydrouridine
Tetrahydrouridine (THU) is potent inhibitor of cytidine deaminase (CDA), which competitively blocks the enzyme's active site more effectively than intrinsic cytidine. |
| Crisnatol
Crisnatol (BWA770U) is a member of the arylmethylaminopropanediol class of DNA intercalators. Crisnatol shows in vitro cytotoxicity against human breast cancer cells. Crisnatol (BWA770U) is also an orally active and anticancer agent. |
| Caf1-IN-1
Caf1-IN-1 is inhibitor for ribonuclease Caf1 with an IC50 of 0.59 µM. Caf1-IN-1 is also a weak inhibitor for poly(A)-specific ribonuclease (PARN) with IC50 of 23.9 µM. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
